Berg to head up ISPE
This article was originally published in Scrip
ISPE, the International Society for Pharmaceutical Engineering, has appointed Nancy Berg as president and CEO. Ms Berg has served as executive director/CEO of the Society of Manufacturing Engineers (SME) and, most recently, as the founder and owner of three small businesses and consultant to both non-profits and for-profits.
You may also be interested in...
The UK's main reimbursement bodies made a series of decisions this week that were broadly favorable and largely focused on oncology medicines.
While troubled Valeant was divesting iNova to private equity investors, Novartis announced a pair of oncology-focused deals, out-licensing a brain cancer drug to Midatech and partnering with IBM Watson Health to optimize breast cancer treatment.
Astellas and Pfizer have amended the PROSPER trial protocol in a bid to position Xtandi ahead of Zytiga in the early stage prostate cancer market.